This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

This study has been terminated.
(unable to meet recruitment goals)
Sponsor:
Information provided by (Responsible Party):
Michael Vaezi, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT01566383
First received: March 26, 2012
Last updated: February 21, 2017
Last verified: February 2017
March 26, 2012
February 21, 2017
March 2012
August 27, 2013   (Final data collection date for primary outcome measure)
Identify normal esophageal MII-pH parameter ranges in healthy volunteers [ Time Frame: Following 24-hr pH monitoring ]
Our aim is to find the normal esophageal MII-pH parameter ranges in volunteers who never experienced reflux related symptoms and are in between the same ranges of age and BMI of our GERD patient population.
Same as current
Complete list of historical versions of study NCT01566383 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population
Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

The normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI). This fact can cause new modifications in the normal values such as making new scales for different age groups or BMI groups.

Our aim is to find the normal esophageal MII-pH parameter ranges in volunteers who never experienced reflux related symptoms and are in between the same ranges of age and BMI of our gastroesophageal reflux disease (GERD) patient population.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Identify Normal MII-pH Parameters
Procedure: 24-hr pH monitoring

Visit 1

The following will be done:

  • A medical history including review of your current drugs;
  • Collection of demographic information;
  • A manometry, before the 24-hour pH testing, to find the junction between the esophagus and stomach;
  • 24-hour pH testing will be done

Visit 2

You will return to the clinic 24 hours after the visit 1 and the following will occur:

  • The catheter will be removed from your nose; and
  • You will return the recording device
Experimental: Healthy Volunteers
Healthy volunteers who are matched (age, weight, gender) to the general patient population undergoing manometry and pH monitoring for GERD will undergo the same procedures to determine pH levels in people without reflux symptoms as compared to pH levels in those patients who have been diagnosed with reflux.
Intervention: Procedure: 24-hr pH monitoring
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
19
August 27, 2013
August 27, 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy male and female adults between the ages of 33-65
  • BMI range of 23.9 - 38.9
  • Ability to give consent to participate in study

Exclusion Criteria:

  • History of extraesophageal reflux disease symptoms such as chronic or acute cough and/or throat clearing and /or non-cardiac chest pain.
  • History of gastroesophageal reflux disease (GERD) such as heartburn and/or regurgitation.
  • History of proton pump inhibitor (PPI) usage ten days prior to the procedure (MII-pH) or H2RA's two days prior to MII-pH and antacids usage on the procedure day.
  • History of thoracic, gastric or esophageal surgery.
  • Histories of Diabetes Mellitus, neurological disorders, gastrointestinal disease, taking medication that alter the intragastric acidity or esophageal motility.
  • Pregnancy or nursing mothers.
  • Alcohol consumption >40g/day, smoking >10cigarettes/day.
Sexes Eligible for Study: All
33 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01566383
120288
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Michael Vaezi, Vanderbilt University Medical Center
Vanderbilt University Medical Center
Not Provided
Principal Investigator: Michael F Vaezi, MD, PhD Vanderbilt University
Vanderbilt University Medical Center
February 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP